First Trust Advisors LP Haemonetics Corp Transaction History

First Trust Advisors LP

  • $108 Billion
  • Q1 2025

A detailed history of First Trust Advisors LP transactions in Haemonetics Corp stock. As of the latest transaction made, First Trust Advisors LP holds 20,990 shares of HAE stock, worth $1.43 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,990
Previous 4,198 400.0%
Holding current value
$1.43 Million
Previous $327,000 307.65%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
BUY
$59.34 - $80.05 $996,437 - $1.34 Million
16,792 Added 400.0%
20,990 $1.33 Million
Q4 2024

Feb 13, 2025
SELL
$71.16 - $93.38 $1.47 Million - $1.93 Million
-20,663 Reduced 83.11%
4,198 $327,000
Q3 2024

Nov 13, 2024
BUY
$72.45 - $91.58 $1.25 Million - $1.57 Million
17,188 Added 224.01%
24,861 $2 Million
Q2 2024

Aug 13, 2024
BUY
$81.24 - $97.37 $114,710 - $137,486
1,412 Added 22.55%
7,673 $634,000
Q1 2024

May 13, 2024
SELL
$71.24 - $85.35 $2.43 Million - $2.91 Million
-34,134 Reduced 84.5%
6,261 $534,000
Q4 2023

Feb 13, 2024
BUY
$80.59 - $92.61 $328,001 - $376,922
4,070 Added 11.2%
40,395 $3.45 Million
Q3 2023

Nov 13, 2023
BUY
$82.56 - $93.49 $176,678 - $200,068
2,140 Added 6.26%
36,325 $3.25 Million
Q2 2023

Aug 14, 2023
SELL
$80.84 - $89.45 $1.16 Million - $1.29 Million
-14,389 Reduced 29.62%
34,185 $2.91 Million
Q1 2023

May 15, 2023
SELL
$72.75 - $90.6 $606,444 - $755,241
-8,336 Reduced 14.65%
48,574 $4.02 Million
Q4 2022

Feb 09, 2023
BUY
$73.85 - $86.14 $3.65 Million - $4.26 Million
49,468 Added 664.71%
56,910 $4.48 Million
Q3 2022

Nov 14, 2022
SELL
$63.3 - $78.66 $110,015 - $136,711
-1,738 Reduced 18.93%
7,442 $551,000
Q2 2022

Aug 12, 2022
SELL
$49.27 - $66.08 $117,016 - $156,940
-2,375 Reduced 20.55%
9,180 $598,000
Q1 2022

May 13, 2022
BUY
$43.77 - $63.22 $127,064 - $183,527
2,903 Added 33.55%
11,555 $731,000
Q4 2021

Feb 08, 2022
BUY
$49.55 - $74.59 $428,706 - $645,352
8,652 New
8,652 $459,000
Q3 2021

Nov 15, 2021
SELL
$57.6 - $70.59 $5.56 Million - $6.81 Million
-96,475 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$51.81 - $118.56 $1.85 Million - $4.23 Million
35,716 Added 58.78%
96,475 $6.43 Million
Q1 2021

May 14, 2021
BUY
$111.01 - $139.48 $603,117 - $757,794
5,433 Added 9.82%
60,759 $6.75 Million
Q4 2020

Feb 02, 2021
BUY
$88.75 - $119.95 $4.91 Million - $6.64 Million
55,326 New
55,326 $6.57 Million
Q3 2020

Nov 05, 2020
SELL
$75.65 - $93.58 $1.68 Million - $2.08 Million
-22,175 Closed
0 $0
Q2 2020

Jul 22, 2020
BUY
$84.96 - $118.91 $1.88 Million - $2.64 Million
22,175 New
22,175 $1.99 Million
Q1 2020

May 06, 2020
SELL
$74.34 - $121.82 $2.33 Million - $3.81 Million
-31,284 Closed
0 $0
Q4 2019

Feb 03, 2020
SELL
$114.37 - $129.46 $829,754 - $939,232
-7,255 Reduced 18.83%
31,284 $3.6 Million
Q3 2019

Nov 04, 2019
BUY
$117.16 - $138.52 $4.52 Million - $5.34 Million
38,539 New
38,539 $4.86 Million
Q2 2019

Jul 30, 2019
SELL
$81.74 - $120.34 $3.05 Million - $4.49 Million
-37,285 Closed
0 $0
Q1 2019

May 09, 2019
SELL
$83.25 - $102.12 $171,495 - $210,367
-2,060 Reduced 5.24%
37,285 $3.26 Million
Q4 2018

Feb 07, 2019
SELL
$90.66 - $116.63 $992,092 - $1.28 Million
-10,943 Reduced 21.76%
39,345 $3.94 Million
Q3 2018

Oct 25, 2018
SELL
$89.96 - $114.58 $98,956 - $126,038
-1,100 Reduced 2.14%
50,288 $5.76 Million
Q2 2018

Aug 02, 2018
BUY
$71.53 - $95.75 $3.68 Million - $4.92 Million
51,388 New
51,388 $4.61 Million

Others Institutions Holding HAE

# of Institutions
352
Shares Held
53.3M
Call Options Held
417K
Put Options Held
314K
View Full List

About HAEMONETICS CORP

HAE Quotes by TradingView
  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.49B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email